February 7, 2019
Research from the University of Pittsburgh School of Medicine in animal models and patient tissues has identified a new molecular pathway in the liver that suggests a commonly used anti-rejection medication could be repurposed to treat certain liver cancers. “What we’ve found is that liver cancers with a specific mutation in the […]